Skip to main content
Pangea Wellness Inc. logo

Pangea Wellness Inc. — Investor Relations & Filings

Ticker · PNGA ISIN · CA6979501039 CSE Manufacturing
Open in API
Filings indexed 244 across all filing types
Latest filing 2025-12-22 Regulatory Filings
Country CA Canada
Listing CSE PNGA

About Pangea Wellness Inc.

https://pangea-wellness.com/

Pangea Wellness Inc. is a North American manufacturer and distributor specializing in clean-label foods and innovative wellness products. The company focuses on creating high-quality, plant-based products that emphasize nutrition, sustainability, and convenience. Pangea Wellness operates through multiple brands, including its subsidiary, Amino Innovations, which develops science-backed wellness solutions. Amino Innovations specializes in advanced peptide therapies (such as BPC and Epitalon) delivered via accessible oral and topical systems, aiming to provide effective alternatives to traditional methods. Pangea Wellness products are distributed across North America, available online and in over 500 premium retail locations.

Recent filings

Filing Released Lang Actions
Final short form prospectus – English.pdf
Regulatory Filings
2025-12-22 English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf
Share Issue/Capital Change Classification · 95% confidence The document is a news release from P2 Gold Inc. announcing the grant of stock options to directors, officers, employees, and consultants. This type of corporate action, specifically the issuance of stock options, falls under the category of capital changes or share-related announcements. Since it specifically details the granting of options rather than a direct share repurchase or a major shareholding notification, it is best classified as a share/capital change announcement.
2025-12-19 English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a 'Certification of Refiled Interim Filings' (Form 52-109F2R). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type (like interim filings), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q2 2025
2025-12-19 English
Interim MD&A (amended) - English.pdf
Management Reports Classification · 100% confidence The document is explicitly titled 'Management’s Discussion and Analysis' (MD&A) and references the 'unaudited condensed interim financial statements for the nine-months ended July 31, 2025'. It provides a detailed narrative explanation of the company's business, operational highlights, and accounting treatment for an acquisition, which is the standard content for an MD&A report. It is not an announcement of a report, but the report itself.
2025-12-19 English
Interim financial statements/report (amended) - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements' for Pangea Wellness Inc. for the three and nine months ended July 31, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Shareholders' Equity, and Statement of Cash Flows) along with detailed notes to the financial statements. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. 9M 2025
2025-12-19 English
News release - English.pdf
Board/Management Information Classification · 85% confidence The document is a press release announcing the appointment of three new strategic advisors to the company's subsidiary, Amino Innovations, and the grant of stock options to officers, directors, and consultants. While it mentions management changes (advisors), it is primarily a corporate announcement regarding business strategy and equity compensation. Given the nature of the announcement (strategic appointments and stock option grants), it fits best under 'Regulatory Filings' (RNS) as a general corporate announcement, as it does not strictly meet the criteria for a formal Board/Management change filing (which usually implies executive/director level changes) or a specific share issuance/capital change (which usually refers to public offerings or major capital structure shifts).
2025-12-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.